COMPANY PROFILE

Avivomed

Developing and commercializing next generation neuromodulaton technology platforms to treat patients suffering from chronic diseases

Roseville, United StatesFounded 2020Health Tech & Medtech

Valuation $100–250M Last recorded · 2021

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Avivomed

Avivomed is a medical device company that develops neuromodulation therapies for chronic diseases. The company is focused on creating minimally invasive treatments that can improve the quality of life for patients with unmet clinical needs.

Avivomed's main product is a neuromodulation platform that uses electrical stimulation to modulate the nervous system. This technology can be used to treat a variety of conditions, including chronic pain, overactive bladder, and fecal incontinence. The company is currently in the development stage and has not yet commercialized its products.

Avivomed is a privately held company that was founded in 2021. The company has raised $3.2 million in Series A financing and is backed by a number of venture capital firms.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: Roseville, United States
Employees: 18
Open positions: None listed
Dealroom signal: 76.3/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, medical implants, Neuromodulation and Neurostimulation, Chronic Disease, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Dec 2021	$32M	$128M	Undisclosed	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Avivomed website traffic

Latest recorded traffic for Avivomed is 1K monthly website visits, up 212.5% over the last three months. Avivomed's team declined 10% over the past year.

Latest monthly visits1K 3-month web change+212.5% 1-year team growth-10%

Monthly website visitsNov 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
RMRivermark MedicalMinimally invasive treatment for Benign Prostatic Hyperplasia, restoring urinary function and enabling early return to daily life	Milwaukee, United States	Operational	17	$55M	$150M
WAWavegateAdvanced spinal cord stimulation platform offering motion-responsive pain relief for chronic conditions	Lake Charles, United States	Operational
MNMotif NeurotechMinimally invasive electronic solutions for mental health	Houston, United States	Operational
CTCore Medical TechnologySpecializes in smart wear and smart medical technology solutions	Ningbo, China	Operational
MSMicro Medical SolutionsProvides practical, successful new answers to some of the most pressing unmet needs in microvascular intervention	Wilmington, United States	Operational
NHNoctrix HealthEarly-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness	Pleasanton, United States	Acquired
SMSaluda MedicalDedicated to improving the lives of people by providing personalized, responsive, and efficient neuromodulation therapy (spinal cord stimulation )	Sydney, Australia	Operational
HYHylomorphHylomorph is an innovative Medtech company engineering biomaterials to optimize the interface between implantable medical devices and tissues	Zurich, Switzerland	Operational